Why is Torrent Pharma falling/rising?

As of 30-Jul, Torrent Pharmaceuticals Ltd. is currently priced at 3,735.00, reflecting a decrease of 43.0 points or 1.14%. Despite this decline, the stock has shown strong performance over the past week and month, with returns of 5.09% and 9.54%, respectively. Today, the stock hit a new 52-week high of Rs. 3,790 before falling, indicating a trend reversal after three consecutive days of gains. Additionally, the stock is trading above its moving averages, and there has been a notable increase in investor participation, with delivery volume rising by 88.5% compared to the five-day average. However, it is important to consider that the stock underperformed its sector by 1.48% today. While the company has demonstrated high management efficiency and consistent returns, it faces risks such as poor long-term growth and a high valuation relative to its earnings growth.
In the broader market context, Torrent Pharmaceuticals has outperformed the Sensex over various periods, including a year-to-date return of 11.31% compared to the Sensex's 4.28%. This indicates that while the stock is currently experiencing a decline, it has been performing well relative to the market overall. The recent price drop may be attributed to profit-taking after reaching a new high, despite the company's strong fundamentals and institutional support. The stock's ability to maintain positive returns over the last three years further emphasizes its resilience, even as it faces challenges in long-term growth and valuation metrics.